Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 10 articles:
HTML format
Text format



Single Articles


    September 2018
  1. BADAMCHI-ZADEH A, Moynihan KD, Larocca RA, Aid M, et al
    Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy.
    J Immunol. 2018 Sep 24. pii: jimmunol.1800885. doi: 10.4049/jimmunol.1800885.
    PubMed     Text format     Abstract available


    August 2018
  2. VIGNERON N, Ferrari V, Van den Eynde BJ, Cresswell P, et al
    Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen.
    J Immunol. 2018 Aug 22. pii: jimmunol.1701479. doi: 10.4049/jimmunol.1701479.
    PubMed     Text format     Abstract available


    March 2018
  3. GODING SR, Wilson KA, Rosinsky C, Antony PA, et al
    PD-L1-Independent Mechanisms Control the Resistance of Melanoma to CD4(+) T Cell Adoptive Immunotherapy.
    J Immunol. 2018 Mar 30. pii: jimmunol.1701617. doi: 10.4049/jimmunol.1701617.
    PubMed     Text format     Abstract available


    October 2017
  4. DING Q, Mohib K, Kuchroo VK, Rothstein DM, et al
    TIM-4 Identifies IFN-gamma-Expressing Proinflammatory B Effector 1 Cells That Promote Tumor and Allograft Rejection.
    J Immunol. 2017;199:2585-2595.
    PubMed     Text format     Abstract available


    May 2017
  5. ZILIO S, Vella JL, De la Fuente AC, Daftarian PM, et al
    4PD Functionalized Dendrimers: A Flexible Tool for In Vivo Gene Silencing of Tumor-Educated Myeloid Cells.
    J Immunol. 2017;198:4166-4177.
    PubMed     Text format     Abstract available


    February 2017
  6. ERKES DA, Smith CJ, Wilski NA, Caldeira-Dantas S, et al
    Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression.
    J Immunol. 2017 Feb 15. pii: 1601064. doi: 10.4049/jimmunol.1601064.
    PubMed     Text format     Abstract available


    January 2017
  7. RAKHMILEVICH AL, Felder M, Lever L, Slowinski J, et al
    Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.
    J Immunol. 2017 Jan 6. pii: 1601255. doi: 10.4049/jimmunol.1601255.
    PubMed     Text format     Abstract available


  8. BALLY AP, Tang Y, Lee JT, Barwick BG, et al
    Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory.
    J Immunol. 2017;198:205-217.
    PubMed     Text format     Abstract available


    December 2016
  9. NASTI TH, Cochran JB, Vachhani RV, McKay K, et al
    IL-23 Inhibits Melanoma Development by Augmenting DNA Repair and Modulating T Cell Subpopulations.
    J Immunol. 2016 Dec 21. pii: 1601455. doi: 10.4049/jimmunol.1601455.
    PubMed     Text format     Abstract available


  10. WISTUBA-HAMPRECHT K, Martens A, Weide B, Teng KW, et al
    Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients.
    J Immunol. 2016 Dec 16. pii: 1600875.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: